BIOLASE Inc (NASDAQ:BIOL)

1.39
Delayed Data
As of Jul 20
 +0.09 / +6.92%
Today’s Change
1.14
Today|||52-Week Range
4.60
-34.80%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close1.30
Today’s open1.31
Day’s range1.29 - 1.43
Volume109,482
Average volume (3 months)78,331
Market cap$28.5M
Data as of 4:00pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)+3.45%
Earnings growth (this year)+32.14%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-9.43%
P/E ratioNM
Price/Sales0.67
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...+0.01+1.14%
PDEXPro-Dex Inc-0.01-0.21%
XRAYDentsply Sirona Inc-0.31-0.68%
ALGNAlign Technology Inc+5.06+1.37%
Data as of 4:00pm ET, 07/20/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$46.9M
Annual profit (last year)-$16.9M
Net profit margin-35.91%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO, CFO &
Principal Accounting Officer
John R. Beaver
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts